310
Views
21
CrossRef citations to date
0
Altmetric
Review

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 3169-3188 | Published online: 09 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Irini Zografaki, Marios Detsis, Maria Del Amo, Raffaella Iantomasi, Ana Maia, Eva Agostina Montuori & Cristina Mendez. (2023) Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data. Expert Review of Vaccines 22:1, pages 545-562.
Read now
Anand P. Dubey, Rashna Dass Hazarika, Veronique Abitbol, Shafi Kolhapure & Someya Agrawal. (2022) Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India. Human Vaccines & Immunotherapeutics 18:1.
Read now
Myron Christodoulides, Maria Victoria Humbert & John E Heckels. (2021) The potential utility of liposomes for Neisseria vaccines. Expert Review of Vaccines 20:10, pages 1235-1256.
Read now
Federico Martinón-Torres, Isabelle Bertrand-Gerentes & Philipp Oster. (2021) A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines 20:9, pages 1123-1146.
Read now
Lidia Serra, Markus Knuf, Federico Martinón-Torres, Kevin Yi & Jamie Findlow. (2021) Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines. Human Vaccines & Immunotherapeutics 17:7, pages 2205-2215.
Read now
Marco Aurelio P. Safadi, Federico Martinón-Torres, Lidia Serra, Cynthia Burman & Jessica Presa. (2021) Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Review of Vaccines 20:4, pages 401-414.
Read now
Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, Bradford D. Gessner, Melvin Kohn, Ron Dagan, Daniel C. Payne, Laia Bruni, Andrew J. Pollard, Adolfo García-Sastre, Denise L. Faustman, Albert Osterhaus, Robb Butler, Francisco Giménez Sánchez, Francisco Álvarez, Myrsini Kaforou, Xabier Bello & Federico Martinón-Torres. (2021) TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Human Vaccines & Immunotherapeutics 17:3, pages 759-772.
Read now

Articles from other publishers (14)

Osamu Matsuoka, Mugen Ujiie, Hitoshi Kikuchi, Sachiko Otake, Danaya Chansinghakul, Takahiro Inoue, Kucku Varghese, Nuchra Sirisuphmitr, Tomoyuki Hashiguchi, Betzana Zambrano, Takahiro Nakama, Carina Frago, Emilia Jordanov & Mandeep Singh Dhingra. (2023) Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Meningococcal Vaccine-Naïve Participants across a Broad Age Range (2–55 Years) in Japan: a Phase III Randomized Study. Japanese Journal of Infectious Diseases 76:3, pages 174-182.
Crossref
Vincenza La Fauci, Daniela Lo Giudice, Raffaele Squeri & Cristina Genovese. (2022) Insight into Prevention of Neisseria Gonorrhoeae: A Short Review. Vaccines 10:11, pages 1949.
Crossref
Giorgia Sulis, Miranda Horn, Ray Borrow & Nicole E. Basta. (2022) A comparison of national vaccination policies to prevent serogroup B meningococcal disease. Vaccine 40:26, pages 3647-3654.
Crossref
Yara Ruiz Garcia, Véronique Abitbol, Michele Pellegrini, Rafik Bekkat-Berkani & Lamine Soumahoro. (2021) A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine. Infectious Diseases and Therapy 11:2, pages 639-655.
Crossref
Myron Christodoulides. (2022) Update on the Neisseria Macrophage Infectivity Potentiator-Like PPIase Protein. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Swarnav Bhakta, Suvendu Choudhury, Joydeep Paul & Arijit Bhattacharya. 2022. COVID-19: Tackling Global Pandemics through Scientific and Social Tools. COVID-19: Tackling Global Pandemics through Scientific and Social Tools 33 49 .
N. N. Kostyukova & V. A. Bekhalo. (2021) Meningococcal Vaccines of New Generations – the First 20 Years of Use. Epidemiology and Vaccinal Prevention 20:4, pages 103-113.
Crossref
F. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli & R. Bekkat-Berkani. (2021) Recent advances in the prevention of meningococcal B disease: Real evidence from 4CMenB vaccination. Vacunas (English Edition) 22:3, pages 189-202.
Crossref
F. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli & R. Bekkat-Berkani. (2021) Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB. Vacunas 22:3, pages 189-202.
Crossref
Mark McMillan, Abira Chandrakumar, Hua Lin Rachael Wang, Michelle Clarke, Thomas R Sullivan, Ross M Andrews, Mary Ramsay & Helen S Marshall. (2021) Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis . Clinical Infectious Diseases 73:3, pages e609-e619.
Crossref
Federico Martinón-Torres, Angelika Banzhoff, Chiara Azzari, Philippe De Wals, Robin Marlow, Helen Marshall, Mariagrazia Pizza, Rino Rappuoli & Rafik Bekkat-Berkani. (2021) Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination. Journal of Infection 83:1, pages 17-26.
Crossref
Carmen I. Baccarini, Michael W. Simon, Donald Brandon, Shane Christensen, Emilia Jordanov & Mandeep S. Dhingra. (2020) Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study. Pediatric Infectious Disease Journal 39:10, pages 955-960.
Crossref
Francesca Mancini, Omar Rossi, Francesca Necchi & Francesca Micoli. (2020) OMV Vaccines and the Role of TLR Agonists in Immune Response. International Journal of Molecular Sciences 21:12, pages 4416.
Crossref
Roberto Rosini, Sonia Nicchi, Mariagrazia Pizza & Rino Rappuoli. (2020) Vaccines Against Antimicrobial Resistance. Frontiers in Immunology 11.
Crossref